metformin vs glp-1 Too Good to Be True?' GLP-1s and Breast Cancer Survival Metformin: Anchoring Potential in GLP-1

Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al

Patel, U

Emerging research suggests these agents may reduce inflammatory markers such as C-reactive protein and pro-inflammatory cytokines through mechanisms independent of weight loss or glucose control

315 The results showed that, in the OA rat model, liraglutide could activate the PKA/CREB signaling pathway and inhibit the inflammatory response through this pathway, thereby alleviating OA symptoms

A smaller share of adults who have ever used these drugs say they stopped taking them because their condition improved (5%)

In fact, women gain an average of 1.5 pounds per year in midlife